2nd Quarter - Report

PRIME POLICY GROUP for ROMARK

Period 2nd Quarter 2022 Filed Jul 20, 2022 Signed by Jacob Beaver

Official filing
Firm
PRIME POLICY GROUP
Client
ROMARK
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

ARPA, emergency use authorization for COVID-19 therapeutic

LobbyistCovered position, as disclosed
PAUL DUSTIN WEISS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

ARPA, emergency use authorization for COVID-19 therapeutic

LobbyistCovered position, as disclosed
PAUL DUSTIN WEISS —

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Disaster Planning/Emergencies DIS

ARPA, emergency use authorization for COVID-19 therapeutic

LobbyistCovered position, as disclosed
PAUL DUSTIN WEISS —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.